Sarepta Therapeutics, Inc. SRPT Settlement Of Capped Call Share Options For2024Notes
Settlement Of Capped Call Share Options For2024Notes at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept srpt:SettlementOfCappedCallShareOptionsFor2024Notes.
The official record: Sarepta Therapeutics, Inc.’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s settlement of capped call share options for2024notes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s settlement of capped call share options for2024notes?
- Sarepta Therapeutics, Inc. (SRPT) reported settlement of capped call share options for2024notes of $0 in Q4 2025.
- How has Sarepta Therapeutics, Inc.'s settlement of capped call share options for2024notes changed year-over-year?
- Sarepta Therapeutics, Inc.'s settlement of capped call share options for2024notes decreased by 100.0% year-over-year, from $11.34M to $0.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s settlement of capped call share options for2024notes?
- Over 3 years (2022 to 2025), Sarepta Therapeutics, Inc.'s settlement of capped call share options for2024notes has grown at a -100.0% compound annual growth rate (CAGR), from $26.32M to $0.
- What does settlement of capped call share options for2024notes mean?
- Reflects cash flows related to the settlement of derivative instruments used to hedge against potential dilution from convertible debt. This activity is typically linked to managing the capital structure and minimizing the impact of stock price volatility on debt conversion.